Search company, investor...
Zyla Life Sciences company logo

Zyla Life Sciences

Founded Year



Acq - P2P | Acquired

Total Raised




About Zyla Life Sciences

Zyla Life Sciences is a specialty pharmaceutical company developing and planning to commercialize abuse-deterrent oral products for the treatment of pain and other indications. The company has created two distinct drug delivery systems, each with abuse-deterrent features and the ability to control the release profile of the active pharmaceutical ingredient. Using its platform, Zyla Life Sciences has developed a pipeline of clinical-stage, opioid-based product candidates in tablet form that are specifically designed to deter abuse by physical and chemical tampering while also providing tailored release of the active pharmaceutical ingredient. The Zyla Life Sciences technology can be applied broadly across different classes of pharmaceutical products and can be used to develop combination products that include multiple APIs with similar or different release profiles. The company's goal is to be a specialty pharmaceutical company focused on the development, manufacture and commercialization of abuse-deterrent pharmaceutical products.On March 17, 2020, Zyla Life Sciences was merged with Assertio Therapeutics.

Headquarters Location

600 Lee Road Suite 100

Wayne, Pennsylvania, 19087,

United States


Missing: Zyla Life Sciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Zyla Life Sciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Zyla Life Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Zyla Life Sciences is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Zyla Life Sciences Patents

Zyla Life Sciences has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Euphoriants, Sedatives, Phenols, Pharmaceutical industry, Dosage forms


Application Date


Grant Date



Related Topics

Euphoriants, Sedatives, Phenols, Pharmaceutical industry, Dosage forms



Latest Zyla Life Sciences News

Knee Osteoarthritis Market 2021 Size, Share, Growth, Trends, Regional Analysis, Key Players, COVID-19 Impact Forecast By Bayer AG, Pfizer, Sanofi, Zyla Life Sciences

Oct 11, 2021

Search jobs 11-Oct-2021 Knee Osteoarthritis Market 2021 Size, Share, Growth, Trends, Regional Analysis, Key Players, COVID-19 Impact Forecast By Bayer AG, Pfizer, Sanofi, Zyla Life Sciences The up-to-date coverage of the latest report Global Knee Osteoarthritis Market 2021 Industry provides a detailed synopsis as well as a consistent evaluation of accurate profits over the forecasted timespan. Current trends, industry analysis, and growth development represented in the report are of great help for the new industry players entering the market. This report presents an in-depth analysis of the Knee Osteoarthritis market size, share, segments, manufacturers, and technologies, key trends, market drivers, challenges, standardization, deployment models, opportunities, future roadmap, and forecast. This market research report includes an in-depth analysis of global and regional markets with the understanding given for variation in the growth of the industry in particular regions, giving a specific investigation of the market status, venture plans, establishment and usage, value patterns. Global Knee Osteoarthritis Market is expected to gain market growth in the forecast period of 2021 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. Download Free Exclusive Sample (350 Pages PDF) Report: To Know the Impact of COVID-19 on this Industry @ The first class Knee Osteoarthritis business report has many strategies that mainly include new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost their footprints in this market. This market study analyses the market status, size, demand, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. This gives more accurate understanding of the market landscape, issues that may affect the industry in the future, and how to best position specific brands. In this report, the base year for estimation is taken as 2021 whereas the historic year is 2019 which will tell how the Knee Osteoarthritis Market is going to perform in the forecast years by informing what the market definition, classifications, applications, and engagements are. Knee Osteoarthritis Market Scenario                             The growth of knee osteoarthritis market enhanced by the growing cases of knee osteoarthritis which create an opportunity for the pharma companies to introduce novel therapy and promising pipeline drugs. In addition, advances in the treatment rate and presence of well-established healthcare facilities are some of the impacting factors for the demand drugs. Nevertheless, huge financial burden and patent expiration are the factors that hinder the growth of this market. Scope of the Report              By Route of Administration (Oral, Parenteral, Others) By End-Users (Hospitals, Homecare, Specialty Clinics, Others) By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy). The Global Knee Osteoarthritis study includes data from 2021 to 2027 useful for industry executives, marketing, sales and product managers, analysts, and anyone looking for market data in easily accessible document. Knee Osteoarthritis Market – Company Profiles Bayer AG ….. Complete Report is Available (Including Full TOC, List of Tables & Figures, Graphs, and Chart) @ This report covers the current scenario and growth prospects of Global Knee Osteoarthritis Market for the period 2021 to 2027. The study is a professional and in-depth study with around – no. of tables which provides statistics of actual scenario of industry and acts as valuable guide to direction companies and individuals interested in the domain. The study elaborates factors of Global Knee Osteoarthritis market such as market opportunities, risk, benefit, opportunity loss and profit along with surveyed customer perspective with a view of Short vs. Long Term goals etc. Global Knee Osteoarthritis Market Scope and Market Size Knee osteoarthritis market is segmented on the basis of treatment type, route of administration, end-users and distribution channel. Based on treatment type, the global knee osteoarthritis market is segmented into medication, surgery and therapy. Route of administration segment for global knee osteoarthritis market is categorized into oral, parenteral and others On the basis of end-users, the global knee osteoarthritis market is segmented into hospitals, homecare, specialty clinics and others. On the basis of distribution channel, the global knee osteoarthritis market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy. The research provides answers to the following key questions: What is the estimated growth rate of the market for the forecast period 2020–2027? What will be the market size during the estimated period? What are the key driving forces responsible for shaping the fate of the Knee Osteoarthritis market during the forecast period? Who are the major market vendors and what are the winning strategies that have helped them occupy a strong foothold in the Knee Osteoarthritis market? What are the prominent market trends influencing the development of the Knee Osteoarthritis market across different regions? What are the major threats and challenges likely to act as a barrier in the growth of the Knee Osteoarthritis market? What are the major opportunities the market leaders can rely on to gain success and profitability? For More Information or Query or Customization Before Buying, Visit @ The Knee Osteoarthritis Market Report Addresses the Following Queries: What is the estimated size of the Knee Osteoarthritis market by 2027? Which segment accounted or a large share of the Knee Osteoarthritis market in the past? Which segment is expected to account the largest market share by 2027? Which governing bodies have approved the use of Knee Osteoarthritis? Which region accounts for a dominant share of the Knee Osteoarthritis market? Which region is anticipated to create lucrative opportunities in the Knee Osteoarthritis market? Some extract from Table of Contents Overview of Global Knee Osteoarthritis Market Knee Osteoarthritis Size (Sales Volume) Comparison by Type (2021-2027) Knee Osteoarthritis Size (Consumption) and Market Share Comparison by Application (2021-2027) Knee Osteoarthritis Size (Value) Comparison by Region (2021-2027) Knee Osteoarthritis Sales, Revenue and Growth Rate (2021-2027) Knee Osteoarthritis Competitive Situation and Trends Players/Suppliers High Performance Pigments Manufacturing Base Distribution, Sales Area, Product Type [,Head-Mounted Displays, Assisted Reality Glasses, Mixed Reality Holographic Displays, Smart Helmets] Analyze competitors, including all important parameters of Knee Osteoarthritis Global Knee Osteoarthritis Manufacturing Cost Analysis Marketing Strategy Analysis, Research Conclusion Check Complete Report with List of Table and Figures@ In conclusion, the Knee Osteoarthritis Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation. Our Reports Will Help Clients Solve the Following Issues: – Insecurity about the future:                                        Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This will help our clients invest or divest their assets. Understanding market opinions: It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track. Understanding the most reliable investment centers: Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research. Evaluating potential business partners: Our research and Insights help our clients identify compatible business partners. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, LATAM, Europe or Southeast Asia or Just Eastern Asia. Our Trending Reports An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Contact Us:

Zyla Life Sciences Frequently Asked Questions (FAQ)

  • When was Zyla Life Sciences founded?

    Zyla Life Sciences was founded in 1995.

  • Where is Zyla Life Sciences's headquarters?

    Zyla Life Sciences's headquarters is located at 600 Lee Road, Wayne.

  • What is Zyla Life Sciences's latest funding round?

    Zyla Life Sciences's latest funding round is Acq - P2P.

  • How much did Zyla Life Sciences raise?

    Zyla Life Sciences raised a total of $51.9M.

  • Who are the investors of Zyla Life Sciences?

    Investors of Zyla Life Sciences include Assertio Therapeutics, Medicxi Ventures, Sunstone Capital, Atlas Venture, Omega Funds and 6 more.

  • Who are Zyla Life Sciences's competitors?

    Competitors of Zyla Life Sciences include Zogenix, Acura Pharmaceuticals, Charleston Laboratories, Embera NeuroTherapeutics, Wilmington Pharmaceuticals and 11 more.

Compare Zyla Life Sciences to Competitors


Naryx Pharma is focused on development of its product candidates of inhaled, nebulized, intranasal drug formulations.


Ameritox is the nation's leader in pain prescription monitoring.

Emagin Therapeutics

Emagin Therapeutics develops new and improved drug entities to treat acute, chronic and cancer-related pain and delivery systems for pain management.


Neorphys is a specialty pharma company focusing on safe pain relief, especially visceral pain management.

Charleston Laboratories

Charleston Laboratories, Inc is a specialty pharmaceutical company focused on the research and development of pain products that prevent or significantly reduce nausea and vomiting, the two most burdensome side effects related to opioid analgesics and other pain associated disease states.

NeuroMolecular Pharmaceuticals

NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders. The Company has built a robust pipeline of neuropsychiatric products based upon its scientists' unique understanding of glutamate's central role in mediating CNS disorders. NeuroMolecular is rapidly advancing its next-generation medicines into clinical studies, with preclinical programs underway in depression, pain, Alzheimer's disease, Parkinson's disease, multiple sclerosis and epilepsy. NeuroMolecular is initially focusing on the development of superior derivatives and dosage formulations of memantine, a drug recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer's disease.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.